Global Search

Search articles, concepts, and chapters

Asia Pac J Ophthalmol (Phila)January 20202 citations

Effect of Metabolic Syndrome on Blood Pressure Changes During Cataract Surgery.

Ono Takashi, Iwasaki Takuya, Sameshima Sayumi, Lee Jinhee, Mori Yosai, Nejima Ryohei, Aihara Makoto, Miyata Kazunori


AI Summary

This study found well-controlled metabolic syndrome did not significantly alter perioperative blood pressure changes during cataract surgery with topical anesthesia, suggesting it doesn't pose an added risk for blood pressure instability.

Abstract

Purpose

To investigate effect of metabolic syndrome on blood pressure during cataract surgery with topical anesthesia.

Design

A single-centered, retrospective case series.

Methods

Consecutive patients who were hospitalized and underwent phacoemulsification and insertion of intraocular lens with topical anesthesia in October 2016 were included. Perioperative blood pressure and pulse pressure were compared between patients with metabolic syndrome (metabolic group) and sex- and age-matched patients without metabolic syndrome (nonmetabolic group) at six time points: on admission, in the morning of the operation, 2 hours before the operation, at the point of entering the operation room, during the operation, and after the operation. Perioperative use of etizolam and nicardipine was compared between the two groups.

Results

Thirty patients in the metabolic group and 30 in the nonmetabolic group were included. There was no difference in changes compared with the values on admission in systolic pressure and pulse pressure at any examination point between the two groups. There was no difference in changes in diastolic pressure between the two groups, except for at 2 hours before the operation (1.4 ± 9.6 mm Hg in the metabolic group vs -6.2 ± 8.5 mm Hg in the nonmetabolic group; P = 0.044). The number of patients who were administered etizolam was 5/30 (16.7%) in the metabolic group and 2/30 (6.7%) in the nonmetabolic group, showing no significant difference. No patients were administered intravenous nicardipine in either group.

Conclusions

Well-controlled metabolic syndrome did not affect the changes in perioperative blood pressure during cataract surgery with topical anesthesia.


MeSH Terms

AgedAged, 80 and overBlood PressureDiazepamFemaleHumansIntraocular PressureLens Implantation, IntraocularMaleMetabolic SyndromeMiddle AgedPhacoemulsificationRetrospective StudiesTranquilizing Agents

Key Concepts4

In a single-centered, retrospective case series of 30 patients with metabolic syndrome and 30 sex- and age-matched patients without metabolic syndrome, there was no difference in changes in systolic pressure and pulse pressure at any examination point between the two groups during cataract surgery with topical anesthesia, compared with values on admission.

PrognosisCase seriesRetrospective Case Seriesn=30 patients with metabolic syndrome, …Ch44

In a single-centered, retrospective case series of 30 patients with metabolic syndrome and 30 sex- and age-matched patients without metabolic syndrome, there was no difference in changes in diastolic pressure between the two groups during cataract surgery with topical anesthesia, except for at 2 hours before the operation (1.4 ± 9.6 mm Hg in the metabolic group vs -6.2 ± 8.5 mm Hg in the nonmetabolic group; P = 0.044).

PrognosisCase seriesRetrospective Case Seriesn=30 patients with metabolic syndrome, …Ch44

In a single-centered, retrospective case series of 30 patients with metabolic syndrome and 30 sex- and age-matched patients without metabolic syndrome, well-controlled metabolic syndrome did not affect the changes in perioperative blood pressure during cataract surgery with topical anesthesia.

PrognosisCase seriesRetrospective Case Seriesn=30 patients with metabolic syndrome, …Ch44

In a single-centered, retrospective case series of 30 patients with metabolic syndrome and 30 sex- and age-matched patients without metabolic syndrome, the number of patients who were administered etizolam was 5/30 (16.7%) in the metabolic group and 2/30 (6.7%) in the nonmetabolic group, showing no significant difference.

Comparative EffectivenessCase seriesRetrospective Case Seriesn=30 patients with metabolic syndrome, …Ch44

Is this article assigned to the wrong chapter(s)? Let us know.